42 items found

Tags: Cancer Science Policy cirrhosis

Filter Results
  • dataset

    r37980778c78--8d30b563767635eff885f4d2fcdf02a3

    Overview of safety data.
  • dataset

    Primers and probes.

    Table 3 indicates primers and probes designed for the 16S rRNA RT-qPCR, the primers described by Fyfe et al., and a re-designed hydrolysis probe used for the amplification,...
  • dataset

    Alcoholic liver disease confers a worse prognosis than HCV infection and non-...

    BackgroundCirrhosis is a heterogeneous clinical condition that includes patients at wide-ranging stages of severity. The role of the underlying liver disease on patient...
  • dataset

    r37980778c78--f822bdbb2dd5260164ef3b2e07a43273

    Summary of the distribution of demographic and clinical variables in the whole study cohort (n = 3417).
  • dataset

    Severe hyperbilirubinemia is associated with higher risk of contrast-related ...

    IntroductionContrast-induced acute kidney injury (CI-AKI) is associated with high risks of morbidity and mortality. Hyperbilirubinemia might have some renal protection but with...
  • dataset

    Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injur...

    BackgroundThe implementation of new serum creatinine (SCr)-based criteria for acute kidney injury (AKI) has brought to light several areas of uncertainty in patients with...
  • dataset

    Characteristics of the cohort according AKI stages.

    Characteristics of the cohort according AKI stages.
  • dataset

    Baseline characteristics of the study cohort.

    JIA: juvenile idiopathic arthritis; TNF: tumor necrosis factor Methotrexate group included patients with JIA who used methotrexate without TNF inhibitors. TNF inhibitor group...
  • dataset

    Incidence of AKI by varying definitions of baseline renal function.

    Incidence of AKI by varying definitions of baseline renal function.
  • dataset

    Quality Assessment of Studies.

    aConfounders of interest were lead-time bias and liver function for survival, liver function, and performance status for treatment eligibility, and liver function and body mass...
  • dataset

    Setting ambitious targets for surveillance and treatment rates among patients...

    BackgroundHepatocelluar cancer (HCC) is the leading cause of death among people with hepatitis C virus (HCV)-related cirrhosis. Our aim was to determine the optimal surveillance...
  • dataset

    Main characteristics of all studies included in the meta-analysis.

    HWE, Hardy-Weinberg equilibrium; LOXL1, lysyl oxidase-like 1; NA, not available; PEXG, pseudoexfoliation glaucoma; PEXS, pseudoexfoliation syndrome; SNP, single nucleotide...
  • dataset

    Baseline demographic and clinical characteristics of study participants at sc...

    Baseline demographic and clinical characteristics of study participants at screening.
  • dataset

    r37980778c78--f2decba706aae2780d5986960f77ace0

    Descriptive distribution of patients who were dually diagnosed with compensated cirrhosis and diabetes by physician mix category, MarketScan 2000–2013.
  • dataset

    r37980778c78--8f5cd4620171acf6b23361cc15efd1f4

    Baseline characteristics of patients.
  • dataset

    Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Precli...

    BackgroundChronic liver scarring from any cause leads to cirrhosis, portal hypertension, and a progressive decline in renal blood flow and renal function. Extreme renal...
  • dataset

    Hospitalized cirrhosis database

    Please see README.xlsx file for variable definitions.
  • dataset

    Characteristics of the study population at inclusion according to the cause o...

    Characteristics of the study population at inclusion according to the cause of cirrhosis.
  • dataset

    r37980778c78--b43e5d7e7a3391961c0e0b533ca03338

    BackgroundThe complications to chronic hepatitis B (HBV) include incidence of hepatocellular carcinoma (HCC) and mortality. The risk of these complications may vary in different...